Chi Steve Chan – Chairman & CEO, Adimmune Corporation, Taiwan
Adimmune Corporation is the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia, as well as the only PIC/S GMP manufacturer of human vaccines in…
Founded in 22nd December 1965, Adimmune Corporation principally engages in R&D, manufacture and sale of vaccines and medicines. Production base is in Tanzi, Taichun. The important well-known product is H1N1 vaccine. IPO issued in Forth January 2010. Our main product is the influenza vaccine. The main product of this company, influenza vaccine, is provided to public in Taiwan by Sanofi-Aventis, Novartis and Glaxo Smith Kline (GSK). Major raw materials are the liquid, syringes, and mice.
Adimmune Corporation is the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia, as well as the only PIC/S GMP manufacturer of human vaccines in…
The president of Adimmune Corporation discusses how the avian flu outbreak of 2006/2007 changed the course of the drug manufacturing industry in Taiwan, what that meant for Adimmune, and how…
Yvonne Huang, VP of Aquavan, a company developing the most sophisticated high-tech green biotechnology platform for the extraction of plants, discusses their innovative technology and business scope while contributing to…
Chin Chun Lin, chairman of Taiwan Leader Biotech Corp., discusses the importance of herbal medicine for preventive healthcare, and shares valuable insights into Taiwan Leader Biotech Corp., a leading company…
Joshua Chang, CEO of RDD Lab, describes the scope of the company’s operations, the expansion of the firm’s capacities, and emerging trends in the CRO industry. Please begin by introducing…
Managing Director Chee Yaw Chek and Regional Customer Manager, Cindy Chan, discuss the importance of Taiwan for DHL, the customer-oriented service they nurture and their focus on ensuring Taiwanese companies…
Frank Douglas, CEO of the TheVax, discusses what he finds so inspiring about innovation in resource-constrained environments, and this Taiwanese biotech’s revolutionary SIT specific immunotherapy platform. The company was founded…
Joanna Yao, general manager of Taiwan & Hong Kong at Baxter, documents the company’s commitment to bring the most innovative renal diseases solutions and expertise to Taiwanese patients and physicians and…
Philips Healthcare Taiwan general manager, Jan Poon, talks about the innovative approach that Philips aims to implement in the local market; spanning from establishing a digital platform to working with…
Eric Tsao, founder of Synermore Biologics, talks about how a company employing 90 people can successfully operate internationally and efficiently progress with its biosimilar and innovative product development pipeline. He…
Ming-Kuei Jang, founder and CEO of Aprinoia, a very promising Taiwan-based company focused on the development of groundbreaking imaging tracers and therapeutics targeting tau-related neurodegenerative diseases, provides insights into the…
James Yang, Director of the Department of Oncology at National Taiwan University Hospital and Director of the Graduate Institute of Oncology at National Taiwan University, discusses the important role of…
Samuel Wang, Honorary President of the Taiwan Generics Pharmaceutical Association (TGPA) and President of the local distributor Weal-Chance Trading, provides insights into the recent international achievements of TGPA and the…
Jacob Lee, co-founder and CEO of DTCO, a Taiwan-based company focused on industrial blockchain services, documents the disruptive impact that the development of the blockchain technology in the healthcare and…
See our Cookie Privacy Policy Here